What's Happening?
Corify Care has received clearance from the U.S. Food and Drug Administration (FDA) for its ACORYS System, a groundbreaking cardiac mapping platform. This system is the first of its kind to offer imageless, non-invasive mapping of cardiac electrical activity
in real-time, providing a comprehensive four-chamber view. The ACORYS System integrates high-resolution 3D anatomical models with real-time electrical activity, enabling a new level of precision in electrophysiology. This technology allows for faster, safer, and more predictable ablation procedures by offering immediate functional insights without the need for pre-procedural imaging or inducing unstable arrhythmias. The system has been validated in over 2,500 patients across Europe and will be showcased at the Heart Rhythm Society 2026 conference in Chicago.
Why It's Important?
The FDA clearance of the ACORYS System marks a significant advancement in the field of electrophysiology, potentially transforming how complex arrhythmias are treated. By providing a complete understanding of arrhythmias before ablation procedures, the system could improve patient outcomes and reduce procedural risks. This innovation is particularly crucial for treating ventricular tachycardia and atrial tachyarrhythmias, where precise mapping is essential. The introduction of this technology in the U.S. market could lead to widespread adoption in electrophysiology centers, enhancing the efficiency and effectiveness of cardiac care.
What's Next?
Following the FDA clearance, Corify Care plans to initiate a phased commercial rollout of the ACORYS System in the United States. The company will partner with leading electrophysiology centers to drive the adoption of this next-generation mapping platform. As the system becomes more widely used, it is expected to influence clinical practices and potentially set new standards in cardiac electrophysiology. The upcoming presentation of new clinical data at the Heart Rhythm Society conference will further highlight the system's capabilities and benefits.
